(NASDAQ: CBUS) Cibus's forecast annual revenue growth rate of 133.06% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 100.07%, and it is also forecast to beat the US market's average forecast revenue growth rate of 25.5%.
Cibus's revenue in 2025 is $3,794,000.On average, 7 Wall Street analysts forecast CBUS's revenue for 2025 to be $231,083,204, with the lowest CBUS revenue forecast at $211,487,000, and the highest CBUS revenue forecast at $262,187,426. On average, 7 Wall Street analysts forecast CBUS's revenue for 2026 to be $485,182,446, with the lowest CBUS revenue forecast at $334,166,831, and the highest CBUS revenue forecast at $569,972,666.
In 2027, CBUS is forecast to generate $3,042,785,504 in revenue, with the lowest revenue forecast at $715,071,421 and the highest revenue forecast at $7,466,641,918.